cilostazol has been researched along with 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3h)-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isaka, Y; Kamada, T; Kambayashi, J; Kawasaki, T; Kimura, K; Mori, T; Sakon, M; Shiba, E; Watase, M | 1 |
| Kawai, C; Murohara, Y; Takatsu, Y; Yui, Y | 1 |
2 other study(ies) available for cilostazol and 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3h)-one
| Article | Year |
|---|---|
Phosphodiesterase inhibitors as antiplatelet agents in vascular surgery.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Animals; Cilostazol; Female; Humans; In Vitro Techniques; Male; Middle Aged; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Quinazolines; Rabbits; Tetrazoles; Vascular Surgical Procedures | 1992 |
[The mode of action and clinical applications of phosphodiesterase inhibitors as anti-platelet drugs].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cilostazol; Coronary Disease; Coronary Thrombosis; Cyclic AMP; Dipyridamole; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Tetrazoles | 1989 |